Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Ophthalmic Solution in Dry Eye Disease
NCT01014078Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of AzaSite in dry eye disease (DED), sponsored by Merck & Co.. Started Oct 2009; status: completed.
02
Drugs
AzaSite
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT01014078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014078.